Lanoxin and Prostate cancer - a phase IV clinical study of FDA data

Summary:

Prostate cancer is reported as a side effect among people who take Lanoxin (digoxin), especially for people who are 60+ old, also take Lasix, and have Osteoporosis.

The phase IV clinical study analyzes which people have Prostate cancer when taking Lanoxin. It is created by eHealthMe based on reports of 21,602 people who have side effects when taking Lanoxin from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Prostate cancer?

Prostate cancer is found to be associated with 998 drugs and 1,210 conditions by eHealthMe. Check the latest studies of Prostate cancer.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

21,602 people reported to have side effects when taking Lanoxin.
Among them, 36 people (0.17%) have Prostate cancer.

Among these 36 people:

What is the age of people who have Prostate cancer when taking Lanoxin? *

What are other drugs people take besides Lanoxin? *

What are other side effects people have besides Prostate cancer? *

Diabetes: 6 people, 16.67%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 16.67%
Fatigue (feeling of tiredness): 6 people, 16.67%
Balance Disorder: 6 people, 16.67%
Presyncope: 6 people, 16.67%
Weakness: 4 people, 11.11%
Nausea (feeling of having an urge to vomit): 4 people, 11.11%
Dyspnea (difficult or laboured breathing): 4 people, 11.11%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 11.11%
Dehydration (dryness resulting from the removal of water): 4 people, 11.11%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 5 people, 13.89%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 11.11%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 5.56%
Pain: 2 people, 5.56%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 5.56%
High Blood Pressure: 2 people, 5.56%
Depression: 2 people, 5.56%
Constipation: 2 people, 5.56%
Cardiac Disorder: 2 people, 5.56%
Swelling: 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and have Prostate cancer?

- Check whether Prostate cancer is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxin:

Lanoxin (21,852 reports)

Prostate cancer treatments and more:

Prostate cancer (224,100 reports)

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prostate cancer:

Prostate cancer (998 drugs)

Browse all the conditions that are associated with Prostate cancer:

Prostate cancer (1,210 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxin) and Lanoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.